Back to search
FDAFDA · Food and drugs·Recall number D-0170-2016

PAPA/PHENTO (30mg/1mg/ml) Injection, 5 mL and 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA

Published November 18, 2015 · Recall initiated: October 7, 2015

Summary

FDA records drug Class II recall D-0170-2016, published November 18, 2015 and initiated October 7, 2015. Recalling firm: Pacific Healthcare, Inc dba B&B Pharmacy; Status: Terminated; Reported quantity: 1-5 ml vial, 3-10 ml vial; Lot: 5 ml --- 07212015@2, exp 1/17/2016; 10 ml --- 05062015@17, exp 11/2/2015; 07082015@10, exp 1/4/2016; 08312015@3, exp 2/20/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pacific Healthcare, Inc dba B&B Pharmacy
Distributor
CA and NJ
Lot
5 ml --- 07212015@2, exp 1/17/2016; 10 ml --- 05062015@17, exp 11/2/2015; 07082015@10, exp 1/4/2016; 08312015@3, exp 2/20/2016
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PAPA/PHENTO (30mg/1mg/ml) Injection, 5 mL and 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA recalled?

Yes. FDA published recall D-0170-2016 on November 18, 2015. Reported hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter